Exhibit 10.26 SCRIPTGEN PHARMACEUTICALS, INC. STOCKHOLDERS AGREEMENT THIS AGREEMENT is made as of December 12, 1997, among SCRIPTGEN Pharmaceuticals, Inc., a Delaware corporation (the "Company"), BioChem Pharma Inc., a Quebec corporation (the...Stockholders Agreement • February 3rd, 1998 • Scriptgen Pharmaceuticals Inc • Pharmaceutical preparations • New York
LICENSE AGREEMENT -----------------License Agreement • February 3rd, 1998 • Scriptgen Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Exhibit 10.15 CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE CONFIDENTIAL PORTIONS HAVE BEEN REDACTED AND ARE DENOTED BY [***]. THE CONFIDENTIAL PORTIONS HAVE BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE...Confidential Treatment • February 3rd, 1998 • Scriptgen Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
RESEARCH AND LICENSE AGREEMENT between BIOCHEM PHARMA, INC. and SCRIPTGEN PHARMACEUTICALS, INC. December 12, 1997Research and License Agreement • February 3rd, 1998 • Scriptgen Pharmaceuticals Inc • Pharmaceutical preparations • New York
CONSULTING AGREEMENTConsulting Agreement • February 3rd, 1998 • Scriptgen Pharmaceuticals Inc • Pharmaceutical preparations
COLLABORATION AND LICENSE AGREEMENT between HOECHST MARION ROUSSEL and SCRIPTGEN PHARMACEUTICALS, INC. October 24, 1997Collaboration and License Agreement • February 3rd, 1998 • Scriptgen Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
UNDERWRITING AGREEMENT UNDERWRITING AGREEMENTUnderwriting Agreement • February 3rd, 1998 • Scriptgen Pharmaceuticals Inc • Pharmaceutical preparations • New York
October 8, 1997 Ms. Karen Hamlin Senior Director of Operations Scriptgen Pharmaceuticals, Inc. 200 Boston Avenue Medford. MA 02155 Re: Amendment to ATLAS Screen Agreement Dear Ms. Hamlin: Pursuant to the agreement dated effective as of May 8, 1997...Agreement • February 3rd, 1998 • Scriptgen Pharmaceuticals Inc • Pharmaceutical preparations • Indiana
RECITALSTesting and Development Agreement • February 3rd, 1998 • Scriptgen Pharmaceuticals Inc • Pharmaceutical preparations • New York
Exhibit 10.37 MATERIAL TRANSFER AND SCREENING AGREEMENT This Agreement, effective as of the date last written below, is between ArQule, Inc. ("ArQule") and Scriptgen Pharmaceuticals, Inc. ("Recipient"). 1. SCREENING OF COMPOUND ARRAY: Within 30 days...Material Transfer and Screening Agreement • February 3rd, 1998 • Scriptgen Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
November 2, 1995 Mr. Thomas A. Bologna President and Chief Executive Officer ScriptGen Pharmaceuticals Medford, Massachussetts 02155 Re: September 22, 1995 Heads of Agreement between ScriptGen and Hoffmann-La Roche Inc.(Roche) Dear Mr. Bologna: This...Scriptgen Pharmaceuticals Inc • February 3rd, 1998 • Pharmaceutical preparations
